Advancing Hope: Accelerating Drug Discovery for FTD – New Awards From a Long-Standing Partnership
Before FTD researchers can initiate a clinical trial of a new medication, they must carry out preclinical testing to better understand its effects on the body, confirm that it binds…
Read MoreWave Life Sciences Ends FTD/ALS Trial of WVE-004
Yesterday, Wave Life Sciences announced that it ended its FOCUS-C9 clinical trial for the drug WVE-004, which was being evaluated as a potential treatment for FTD and amyotrophic lateral sclerosis…
Read MoreAdvancing Hope: Major Leaders in FTD and ALS Research Gather in Arizona for Summit on C9orf72 Gene
In March, prominent leaders in FTD and ALS research gathered in Scottsdale, Arizona, for the first-ever summit on the C9orf72 gene, variations of which constitute the most common cause of…
Read MoreFTD Can Produce a Creative Spark in Some, Study Finds
Brain atrophy patterns specific to FTD can let loose previously suppressed creative abilities in some people diagnosed with the disease, according to a study published earlier this year in JAMA…
Read More“What Do People with PPA Want from Speech-Language Therapy?” Recent Study Asks
A study published in the International Journal of Language and Communication Disorders explores the needs of people affected by primary progressive aphasia (PPA) and how speech-language therapy (SLT) can be…
Read MoreMay’s Athlete of the Month: Dane Sundseth
AFTD’s May Charity Miles Athlete of the Month is Dane Sundseth from Southern California! After a friend of his family member was diagnosed with FTD, Dane made a choice to…
Read More
English 
Spanish (Mexico) 
French 
German 
Swedish 
Portuguese 
Italian 
Dutch 
Danish 
Polish 
Spanish (Spain)